Cara Therapeutics | CARA - EPS Earnings Per Share


Cara Therapeutics reported $-0.72 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Cara Therapeutics USD -0.72 0.14 Mar/2026
Cassava Sciences USD -0.21 0.05 Mar/2026
Chugai Pharma JPY 70.69 0.56 Jun/2026
Cipla INR 9.76 2.9 Jun/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.23 0.82 Mar/2026
CSL USD 5.07 3 Dec/2025
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Pacira USD 0.73 0.13 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
RedHill Biopharma USD -1.31 33.38 Jun/2024
Supernus Pharmaceuticals USD -1.01 1.61 Jun/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024